Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-01

Clinical Trial Update: Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX. [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating a novel method (SS-RBX) for assessing urethral function in stress urinary incontinence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pfizer | Conditions: Urinary Incontinence, Stress | Phase 2 | Status: COMPLETED